Skip to main content

Bortezomib News

FDA Approves Darzalex (daratumumab) in Combination with Two Standard of Care Regimens for the Treatment of Patients with Multiple Myeloma Who Have Received At Least One Prior Therapy

HORSHAM, PA, Nov. 21, 2016 – Janssen Biotech, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved Darzalex (daratumumab) in combination with lenalidomide and dexamethasone, o...

FDA Approves Subcutaneous Administration of Velcade In All Approved Indications

CAMBRIDGE, Mass., January 23, 2012–Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Multiple Myeloma, Lymphoma

Bortezomib patient information at Drugs.com